MRI findings in neuroferritinopathy

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Ohta, Emiko ^a   Takiyama, Yoshihisa ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865601614     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/197438     Document Type: Review

References (37)

1. Curtis A. R. J., Fey C., Morris C. M., Bindoff L. A., Ince P. G., Chinnery P. F., Coulthard A., Jackson M. J., Jackson A. P., McHale D. P., Hay D., Barker W. A., Markham A. F., Bates D., Curtis A., Burn J., Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nature Genetics 2001 28 4 350 354 2-s2.0-0034941118 10.1038/ng571 (Pubitemid 32702424)
2. Vidal R., Ghetti B., Takao M., Brefel-Courbon C., Uro-Coste E., Glazier B. S., Siani V., Benson M. D., Calvas P., Miravalle L., Rascol O., Delisle M. B., Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. Journal of Neuropathology and Experimental Neurology 2004 63 4 363 380 2-s2.0-12144288949 (Pubitemid 38429033)
3. Mancuso M., Davidzon G., Kurlan R. M., Tawil R., Bonilla E., Di Mauro S., Powers J. M., Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. Journal of Neuropathology and Experimental Neurology 2005 64 4 280 294 2-s2.0-16844363930 (Pubitemid 40489555)
4. Maciel P., Cruz V. T., Constante M., Iniesta I., Costa M. C., Gallati S., Sousa N., Sequeiros J., Coutinho P., Santos M. M., Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 2005 65 4 603 605 2-s2.0-23844553465 10.1212/01.wnl.0000178224.81169. c2 (Pubitemid 41170724)
5. Ohta E., Nagasaka T., Shindo K., Toma S., Nagasaka K., Ohta K., Shiozawa Z., Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology 2008 70 16, part 2 1493 1494 2-s2.0-42049109697 10.1212/01.wnl.0000310428.74624.95 (Pubitemid 351521946)
6. Devos D., Tchofo P. J., Vuillaume I., Deste A., Batey S., Burn J., Chinnery P. F., Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain 2009 132 6 e109 2-s2.0-67649414590 10.1093/brain/awn274
7. Kubota A., Hida A., Ichikawa Y., Momose Y., Goto J., Igeta Y., Hashida H., Yoshida K., Ikeda S. I., Kanazawa I., Tsuji S., A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Movement Disorders 2009 24 3 441 445 2-s2.0-67651103065 10.1002/mds.22435
8. Levi S., Cozzi A., Arosio P., Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. Best Practice and Research: Clinical Haematology 2005 18 2 265 276 2-s2.0-14544294357 10.1016/j.beha.2004. 08.021 (Pubitemid 40298369)
9. Vidal R., Miravalle L., Gao X., Barbeito A. G., Baraibar M. A., Hekmatyar S. K., Widel M., Bansal N., Delisle M. B., Ghetti B., Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. Journal of Neuroscience 2008 28 1 60 67 2-s2.0-38149140232 10.1523/JNEUROSCI.3962-07.2008
10. Rouault T. A., Iron on the brain. Nature Genetics 2001 28 4 299 300 2-s2.0-0034935074 10.1038/91036 (Pubitemid 32702411)
11. Ke Y., Qian Z. M., Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurology 2003 2 4 246 253 2-s2.0-0345714885 10.1016/S1474-4422(03)00353-3 (Pubitemid 37443312)
12. Cozzi A., Rovelli E., Frizzale G., Campanella A., Amendola M., Arosio P., Levi S., Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy. Neurobiology of Disease 2010 37 1 77 85 2-s2.0-70449519036 10.1016/j.nbd.2009.09.009
13. Chinnery P. F., Crompton D. E., Birchall D., Jackson M. J., Coulthard A., Lombès A., Quinn N., Wills A., Fletcher N., Mottershead J. P., Cooper P., Kellett M., Bates D., Burn J., Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007 130 1 110 119 2-s2.0-33845899114 10.1093/brain/awl319 (Pubitemid 46026227)
14. McNeill A., Birchall D., Hayflick S. J., Gregory A., Schenk J. F., Zimmerman E. A., Shang H., Miyajima H., Chinnery P. F., T2 and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008 70 18 1614 1619 2-s2.0-42949158787 10.1212/01.wnl.0000310985. 40011.d6 (Pubitemid 351620317)
15. Mir P., Edwards M. J., Curtis A. R. J., Bhatia K. P., Quinn N. P., Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene. Movement Disorders 2005 20 2 243 245 2-s2.0-14944341764 10.1002/mds.20280 (Pubitemid 40361132)
16. Crompton D. E., Chinnery P. F., Bates D., Walls T. J., Jackson M. J., Curtis A. J., Burn J., Spectrum of movement disorders in neuroferritinopathy. Movement Disorders 2005 20 1 95 98 2-s2.0-14044262975 10.1002/mds.20284 (Pubitemid 40277514)
17. Caparros-Lefebvre D., Destée A., Petit H., Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system? Journal of Neurology, Neurosurgery and Psychiatry 1997 63 2 196 203 2-s2.0-0030813306 (Pubitemid 27388969)
18. Crompton D. E., Chinnery P. F., Fey C., Curtis A. R., Morris C. M., Kierstan J., Burt A., Young F., Coulthard A., Curtis A., Ince P. G., Bates D., Jackson M. J., Burn J., Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells, Molecules and Diseases 2002 29 3 522 531 2-s2.0-0041952925
19. Harrison P. M., Arosio P., The ferritins: molecular properties, iron storage function and cellular regulation. Biochimica et Biophysica Acta 1996 1275 3 161 203 2-s2.0-0030608152 10.1016/0005-2728(96)00022-9 (Pubitemid 26248989)
20. Olanow C. W., Arendash G. W., Metals and free radicals in neurodegeneration. Current Opinion in Neurology 1994 7 6 548 558 2-s2.0-0027944855 (Pubitemid 24365668)
21. Morris C. M., Candy J. M., Oakley A. E., Bloxham C. A., Edwardson J. A., Histochemical distribution of non-haem iron in the human brain. Acta Anatomica 1992 144 3 235 257 2-s2.0-0026739170
22. Stankiewicz J., Panter S. S., Neema M., Arora A., Batt C. E., Bakshi R., Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007 4 3 371 386 2-s2.0-34250783638 10.1016/j.nurt.2007.05.006 (Pubitemid 46962416)
23. Gregory A., Polster B. J., Hayflick S. J., Clinical and genetic delineation of neurodegeneration with brain iron accumulation. Journal of Medical Genetics 2009 46 2 73 80 2-s2.0-62149099955 10.1136/jmg.2008.061929
24. Chinnery P. F., Curtis A. R. J., Fey C., Coulthard A., Crompton D., Curtis A., Lombés A., Burn J., Neuroferritinopathy in a French family with late onset dominant dystonia. Journal of Medical Genetics 2003 40 5 e69 2-s2.0-0043280850
25. Ory-Magne F., Brefel-Courbon C., Payoux P., Debruxelles S., Sibon I., Goizet C., Labauge P., Menegon P., Uro-Coste E., Ghetti B., Delisle M. B., Vidal R., Rascol O., Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC). Movement Disorders 2009 24 11 1676 1683 2-s2.0-69949153449 10.1002/mds.22669
26. Ohta E., Nagasaka T., Shindo K., Toma S., Nagasaka K., Miwa M., Takiyama Y., Shiozawa Z., Clinical features of neuroferritinopathy. Clinical Neurology 2009 49 5 254 261 2-s2.0-67849092029
27. Wills A. J., Sawle G. V., Guilbert P. R., Curtis A. R. J., Palatal tremor and cognitive decline in neuroferritinopathy. Journal of Neurology Neurosurgery and Psychiatry 2002 73 1 91 92 2-s2.0-0036298867 10.1136/jnnp.73.1.91 (Pubitemid 34713030)
28. Burn J., Chinnery P. F., Neuroferritinopathy. Seminars in Pediatric Neurology 2006 13 3 176 181 2-s2.0-33750686631 10.1016/j.spen.2006.08.006 (Pubitemid 44709654)
29. Zhou B., Westaway S. K., Levinson B., Johnson M. A., Gitschier J., Hayflick S. J., A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics 2001 28 4 345 349 2-s2.0-0034935036 10.1038/ng572 (Pubitemid 32702423)
30. Hayflick S. J., Hartman M., Coryell J., Gitschier J., Rowley H., Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. American Journal of Neuroradiology 2006 27 6 1230 1233 2-s2.0-33747404210 (Pubitemid 44897631)
31. Hayflick S. J., Westaway S. K., Levinson B., Zhou B., Johnson M. A., Ching K. H. L., Gitschier J., Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. New England Journal of Medicine 2003 348 1 33 40 2-s2.0-0037413484 10.1056/NEJMoa020817 (Pubitemid 36026344)
32. Sharma M. C., Aggarwal N., Bihari M., Goyal V., Gaikwed S., Vaishya S., Sarkar C., Hallervorden Spatz disease: MR and pathological findings of a rare case. Neurology India 2005 53 1 102 104 2-s2.0-17444391231 (Pubitemid 40545214)
33. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S., Kato M., Yanagisawa N., Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Annals of Neurology 1995 37 5 646 656 2-s2.0-0029007765 10.1002/ana.410370515
34. Kóbor J., Javaid A., Omojola M. F., Cerebellar hypoperfusion in infantile neuroaxonal dystrophy. Pediatric Neurology 2005 32 2 137 139 2-s2.0-12344314207 10.1016/j.pediatrneurol.2004.08.004 (Pubitemid 40138700)
35. Paisan-Ruiz C., Bhatia K. P., Li A., Hernandez D., Davis M., Wood N. W., Hardy J., Houlden H., Singleton A., Schneider S. A., Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Annals of Neurology 2009 65 1 19 23 2-s2.0-60849121924 10.1002/ana.21415
36. Péran P., Hagberg G., Luccichenti G., Cherubini A., Brainovich V., Celsis P., Caltagirone C., Sabatini U., Voxel-based analysis of R2 maps in the healthy human brain. Journal of Magnetic Resonance Imaging 2007 26 6 1413 1420 2-s2.0-37349072485 10.1002/jmri.21204 (Pubitemid 350291267)
37. Cherubini A., Péran P., Caltagirone C., Sabatini U., Spalletta G., Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 2009 48 1 29 36 2-s2.0-68049105099 10.1016/j.neuroimage.2009.06.035